SOM Biotech Announces the Presentation of the Phase IIb Study Results in Huntington’s Chorea Patients at the HDG Conference in Cincinnati
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary artificial intelligence platform, announces the presentation …